BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7602463)

  • 1. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
    Boisdron-Celle M; Menei P; Benoit JP
    J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.
    Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH
    J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
    Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP
    Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
    Sehra S; Dhake AS
    J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y; Sturek M; Park K
    Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of biodegradable drug delivery system to treat addiction.
    Mandal TK
    Drug Dev Ind Pharm; 1999 Jun; 25(6):773-9. PubMed ID: 10349563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
    Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
    De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
    J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of heparin-loaded polymeric microparticles.
    Jiao YY; Ubrich N; Hoffart V; Marchand-Arvier M; Vigneron C; Hoffman M; Maincent P
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1033-41. PubMed ID: 12378958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
    Pistel KF; Bittner B; Koll H; Winter G; Kissel T
    J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.
    Lamprecht A; Ubrich N; Hombreiro Pérez M; Lehr C; Hoffman M; Maincent P
    Int J Pharm; 1999 Jul; 184(1):97-105. PubMed ID: 10425355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Yeh MK
    J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.
    Hausberger AG; DeLuca PP
    J Pharm Biomed Anal; 1995 May; 13(6):747-60. PubMed ID: 7669829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable microparticles for the controlled delivery of oligonucleotides.
    De Rosa G; Quaglia F; La Rotonda M; Besnard M; Fattal E
    Int J Pharm; 2002 Aug; 242(1-2):225-8. PubMed ID: 12176251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.